Ravulizumab, CAS [[1803171-55-2]]

Produktübersicht

• Artikelname: Ravulizumab, CAS [[1803171-55-2]]
• Artikelnummer: TGM-T76867
• Hersteller Artikelnummer: T76867
• Alternativnummer: TGM-T76867-1MG,TGM-T76867-5MG,TGM-T76867-10MG,TGM-T76867-25MG,TGM-T76867-50MG,TGM-T76867-100MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: ALXN1210

Produktbeschreibung

Ravulizumab (ALXN1210) is a humanized monoclonal antibody that specifically binds to human complement protein C5 with high affinity, targeting complement factor 5 to block complement activation. It can be used for the prevention and treatment of paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis.

Produkteigenschaften

• Reinheit: >95%
• CAS Nummer: [1803171-55-2]
• Target-Kategorie: Complement System